Likmez Suspension
Product Images NDC 71656-066

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Likmez (NDC 71656-066). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Saptalis Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Image01 V1)

Label (Image01 V1)
Label for LIKMEZ (metronidazole) Oral Suspension, 100 mg/mL (500 mg/5 mL) in strawberry peppermint flavor. The 200 mL bottle label from Saptalis Pharmaceuticals, LLC includes directions to shake well, storage instructions, and a discard timeframe of 60 days after opening. The label features dosage and safety notes, a barcode, and manufacturer information.*
FDA Label Image

Structure (Structure01)

Structure (Structure01)
Chemical structure of Metronidazole showing a nitroimidazole ring with attached nitro, methyl, and hydroxyethyl groups as the active ingredient in the product LIKMEZ Metronidazole Oral Suspension 100 mg/mL by Saptalis Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.